The new national asthma education and prevention program's guidelines on the diagnosis and management of asthma and childhood asthma treatment

Pediatric Asthma, Allergy and Immunology

Volumn 20, Issue 4, 2007, Pages 263-268

  Kelly, H William ^a,b  

^a Department of Pediatrics   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; CHILDHOOD DISEASE; CLINICAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 38649106505     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.2007.9992     Document Type: Review

References (22)

1. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program, Expert Panel Report 3. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 07-4051. Bethesda, MD, US Department of Health and Human Services, 2007. Accessible at http://www.nhlbi.nih.gov Last accessed January 8, 2008.
2. Castro-Rodriguez JA, Rodrigo GJ. β-agonists through metered-dose inhalers with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: A systematic review with meta-analysis. J Pediatr 2004; 145:172-177.
3. Plotnick LH, Ducharme FM. Should inhaled anticholinergics be added to β2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ 1998; 317:971-977.
4. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children. A dose comparison study. Am J Respir Crit Care Med 1999; 160:126-131.
5. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354:1985-1997.
6. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004; 113: e87-e94.
7. Qaqunda PY, Sugerman RW, Ceruti E, Maspero JF, Kleha JF, Scott CA, et al. Efficacy and safety of inhaled fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-schoolage children with asthma: A randomized, double-blind, placebo-controlled study. J Pediatr 2006; 149: 663-670.
8. U.S. Food and Drug Administration. Center for Drug Evaluation and Research, Pediatric Drug Development. http://www.fda.gov/cder/pediatric/index. htm. Last accessed July 5, 2006.
9. van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. Curr Med Res Opin 2005; 21:971-979.
10. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-1063.
11. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: A meta-analysis. Pediatrics 2000; 106:E8.
12. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen Y-Z, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: A randomized, double-blind trial. Lancet 2003; 361:1071-1076.
13. Kelly HW. Potential adverse effects of inhaled corticosteroids. J Allergy Clin Immunol 2003; 112:469-478.
14. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343:1054-1063.
15. Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007; 119:64-72.
16. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the diagnosis and management of asthma-Update on selected topics 2002. NIH publication 03-5074, 2003. Accessible at http://www.nhlbi.nih.gov/guidelines/asthma Last accessed January 8, 2008.
17. 2 agonists (LABAs) in children and the new "Black Box" warning. Pediatr Asthma, Allergy Immunol 2006; 19:126-131.
18. 2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003; 36:391-398.
19. 2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev 2005; 4:CD005533.
20. Verberne AAPH, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. Am J Respir Crit Care Med 1998; 158: 213-219.
21. Van den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI. Salmeterol/fluticasone propionate (50/100 μg) in combination in a Diskus™ inhaler (Seretide™) is effective and safe in children with asthma. Pediatr Pulmonol 2000; 30:97-105.
22. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: A new strategy in pediatric asthma. Chest 2006; 130:1733-1743.